Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:December 21, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:December 21, 2023Active, not recruiting
Condition(s):Endogenous HyperinsulinismLast Updated:July 27, 2023Recruiting
Condition(s):Type 2 Diabetes MellitusLast Updated:November 8, 2016Completed
Condition(s):HealthyLast Updated:January 9, 2015Completed
Condition(s):Type 2 DiabetesLast Updated:July 12, 2023Completed
Condition(s):Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies); Healthy Subjects (Treated With no Diabetes Therapies)Last Updated:April 15, 2015Completed
Condition(s):Alcohol Use DisorderLast Updated:February 9, 2022Terminated
Condition(s):Type 2 Diabetes MellitusLast Updated:February 24, 2015Completed
Condition(s):Acute Ischemic StrokeLast Updated:September 14, 2021Unknown status
Condition(s):Diabetes Mellitus, Type 2Last Updated:July 3, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.